Entry - #601042 - DYSTONIA 9; DYT9 - OMIM
# 601042

DYSTONIA 9; DYT9


Alternative titles; symbols

CHOREOATHETOSIS/SPASTICITY, EPISODIC
CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA
CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
1p34.2 Dystonia 9 601042 AD 3 SLC2A1 138140
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
HEAD & NECK
Eyes
- Diplopia
NEUROLOGIC
Central Nervous System
- Ataxia, episodic
- Spasticity
- Dysarthria
- Dystonia
- Involuntary movements
- Dyskinesias
- Choreoathetosis
- Spastic paraplegia
- Hyperreflexia
- Pyramidal signs
- Tonic-clonic seizures (less common)
- Migraine
- Headache
- Cognitive impairment
Peripheral Nervous System
- Paresthesias
MISCELLANEOUS
- Onset at 2 to 15 years
- Symptoms precipitated by stress, exertion, fatigue, alcohol
- Variable features
- Some patients respond to acetazolamide
MOLECULAR BASIS
- Caused by mutation in the solute carrier family 2 (facilitated glucose transporter), member 1 gene (SLC2A1, 138140.0018)
Dystonia - PS128100 - 37 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.32-p36.13 Dystonia 13, torsion AD 2 607671 DYT13 607671
1p35.3 Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities AR 3 617282 MECR 608205
1p35.1 Dystonia 2, torsion, autosomal recessive AR 3 224500 HPCA 142622
1p34.2 GLUT1 deficiency syndrome 2, childhood onset AD 3 612126 SLC2A1 138140
1p34.2 Dystonia 9 AD 3 601042 SLC2A1 138140
2p22.2 Dystonia 33 AD, AR 3 619687 EIF2AK2 176871
2q14.3-q21.3 Dystonia 21 AD 2 614588 DYT21 614588
2q31 Paroxysmal nonkinesigenic dyskinesia 2 AD 2 611147 PNKD2 611147
2q31.2 Dystonia 16 AR 3 612067 PRKRA 603424
2q35 Paroxysmal nonkinesigenic dyskinesia 1 AD 3 118800 PNKD 609023
2q37.3 Dystonia 27 AR 3 616411 COL6A3 120250
3p13 ?Dystonia 35, childhood-onset AR 3 619921 SHQ1 613663
4q21.1 Dystonia 37, early-onset, with striatal lesions AR 3 620427 NUP54 607607
5q22.3 ?Dystonia 34, myoclonic AD 3 619724 KCNN2 605879
7q21.3 Dystonia-11, myoclonic AD 3 159900 SGCE 604149
8p11.21 Dystonia 6, torsion AD 3 602629 THAP1 609520
9q22.32 Dystonia 31 AR 3 619565 AOPEP 619600
9q34 Dystonia 23 AD 2 614860 DYT23 614860
9q34.11 Dystonia-1, torsion AD 3 128100 TOR1A 605204
11p14.3-p14.2 Dystonia 24 AD 3 615034 ANO3 610110
11q13.2 Episodic kinesigenic dyskinesia 3 AD 3 620245 TMEM151A 620108
11q23.3 ?Dystonia 32 AR 3 619637 VPS11 608549
14q22.2 Dystonia, DOPA-responsive AD, AR 3 128230 GCH1 600225
16p11.2 Episodic kinesigenic dyskinesia 1 AD 3 128200 PRRT2 614386
16q13-q22.1 Episodic kinesigenic dyskinesia 2 AD 2 611031 EKD2 611031
17q22 ?Dystonia 22, adult-onset AR 3 620456 TSPOAP1 610764
17q22 Dystonia 22, juvenile-onset AR 3 620453 TSPOAP1 610764
18p11 Dystonia-15, myoclonic AD 2 607488 DYT15 607488
18p Dystonia-7, torsion AD 2 602124 DYT7 602124
18p11.21 Dystonia 25 AD 3 615073 GNAL 139312
19p13.3 Dystonia 4, torsion, autosomal dominant AD 3 128101 TUBB4A 602662
19q13.12 Dystonia 28, childhood-onset AD 3 617284 KMT2B 606834
19q13.2 Dystonia-12 AD 3 128235 ATP1A3 182350
20p13 Dystonia 30 AD 3 619291 VPS16 608550
20p11.2-q13.12 Dystonia-17, primary torsion AR 2 612406 DYT17 612406
22q12.3 Dystonia 26, myoclonic AD 3 616398 KCTD17 616386
Xq13.1 Dystonia-Parkinsonism, X-linked XLR 3 314250 TAF1 313650

TEXT

A number sign (#) is used with this entry because dystonia-9 (DYT9) is caused by heterozygous mutation in the SLC2A1 gene (138140), also referred to as GLUT1, on chromosome 1p34.

Allelic disorders with overlapping features include GLUT1 deficiency syndrome-1 (GLUT1DS1; 606777), GLUT1DS2 (612126), and idiopathic generalized epilepsy-12 (EIG12; 614847).


Description

Dystonia-9 is an autosomal dominant neurologic disorder characterized by childhood onset of paroxysmal choreoathetosis and progressive spastic paraplegia. Most show some degree of cognitive impairment. Other variable features may include seizures, migraine headaches, and ataxia (summary by Weber et al., 2011).


Clinical Features

Auburger et al. (1996) described a large German pedigree with autosomal dominant paroxysmal choreoathetosis and spasticity. A total of 18 affected and 11 unaffected family members were clinically evaluated. Age of onset ranged from 2 to 15 years, with most individuals presenting clear symptoms before attending school. Patients complained of episodes of involuntary movements, dystonic posture of toes, legs, and arms, imbalance, dysarthria, paresthesias periorally and on the lower limbs, and double vision, sometimes accompanied or followed by headache. Cerebellar ataxia was not seen in the episodes observed. The episodes lasted approximately 20 minutes, and occurred at frequencies ranging from twice a day to twice a year. Physical exercise, emotional stress, lack of sleep, and alcohol consumption were mentioned as precipitating factors. While physical examination was usually normal in the clinical interval, 5 patients exhibited constant spastic paraplegia as evidenced by spastic leg tone, increased tendon reflexes, and pyramidal signs in the lower limbs, without increased latencies on motor evoked potential analysis. Affected individuals were described as good natured and simple minded; 1 patient was 'analphabetic.'

Weber et al. (2011) reported Australian adult monozygotic twin brothers with DYT9 and mental retardation. They presented with paroxysmal choreoathetosis and progressive spastic paraparesis; ataxia was not observed. As toddlers, they both developed episodic stereotyped, abnormal movements mainly affecting the limbs. The movements progressed to vigorous choreatic movements without impairment of consciousness. Episodes lasted between 5 minutes and 2 hours, and occurred several times weekly. Precipitating factors included prolonged exercise or physical exhaustion, dehydration, caffeine, alcohol, and anticipation of food. Medication was not beneficial for these episodes. In addition, both had a persistent gait disturbance due to progressive spastic paraparesis since later childhood, with markedly increased tone, sustained clonus, pyramidal pattern weakness, brisk reflexes, and extensor plantar responses.


Inheritance

The transmission pattern of paroxysmal choreoathetosis in the family reported by Auburger et al. (1996) was consistent with autosomal dominant inheritance.


Clinical Management

Bain et al. (1992) demonstrated a rise in pH in the cerebellum with (31)P nuclear magnetic resonance spectroscopy in 6 affected members of 2 unrelated families with familial periodic cerebellar ataxia consistent with ataxia (see 108500). Consistent with this finding, acetazolamide stopped or alleviated symptoms. In contrast, Auburger et al. (1996) found no clear elevation of pH in their family. They stated, however, that episodes ceased in one patient after administration of acetazolamide and phenytoin and were ameliorated in a second patient by acetazolamide but continued in a third patient despite treatment with a range of agents.


Mapping

By linkage analysis in a large pedigree with paroxysmal choreoathetosis with episodic ataxia and spasticity, Auburger et al. (1996) concluded that the gene for this disorder probably lies in a 2-cM region between D1S443 and D1S197. They noted that a cluster of potassium channel genes is located on 1p.


Molecular Genetics

In affected members of the family with DYT9 originally reported by Auburger et al. (1996), Weber et al. (2011) identified a heterozygous mutation in the SLC2A1 gene (R232C; 138140.0018). Two Australian brothers with the disorder carried a different heterozygous mutation (R126C; 138140.0014).


Nomenclature

Muller et al. (1998) referred to this disorder as dystonia-9 and suggested that it is closely related to paroxysmal dystonic choreoathetosis (PDC; 118800), which they referred to as dystonia-8. The involuntary movements and dystonia in DYT9 are similar to those in PDC, which maps to chromosome 2. In both disorders, episodes can be induced by alcohol, fatigue, and emotional stress; however, in DYT9, physical exercise can precipitate the episodes, and 5 of the 18 patients studied by Auburger et al. (1996) had spastic paraplegia both during and between episodes of dyskinesia.


REFERENCES

  1. Auburger, G., Ratzlaff, T., Lunkes, A., Nelles, H. W., Leube, B., Binkofski, F., Kugel, H., Heindel, W., Seitz, R., Benecke, R., Witte, O. W., Voit, T. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 31: 90-94, 1996. [PubMed: 8808284, related citations] [Full Text]

  2. Bain, P. G., O'Brien, M. D., Keevil, S. F., Porter, D. A. Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann. Neurol. 31: 147-154, 1992. [PubMed: 1575453, related citations] [Full Text]

  3. Muller, U., Steinberger, D., Nemeth, A. H. Clinical and molecular genetics of primary dystonias. Neurogenetics 1: 165-177, 1998. [PubMed: 10737119, related citations] [Full Text]

  4. Weber, Y. G., Kamm, C., Suls, A., Kempfle, J., Kotschet, K., Schule, R., Wuttke, T. V., Maljevic, S., Liebrich, J., Gasser, T., Ludolph, A. C., Van Paesschen, W., Schols, L., De Jonghe, P., Auburger, G., Lerche, H. Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology 77: 959-964, 2011. [PubMed: 21832227, related citations] [Full Text]


Cassandra L. Kniffin - updated : 10/4/2012
Victor A. McKusick - updated : 5/5/1998
Orest Hurko - updated : 4/1/1996
Creation Date:
Victor A. McKusick : 2/6/1996
carol : 05/11/2017
joanna : 05/10/2013
carol : 10/9/2012
ckniffin : 10/4/2012
ckniffin : 10/4/2012
alopez : 4/6/2010
joanna : 3/18/2004
carol : 5/22/1998
carol : 5/16/1998
carol : 5/13/1998
terry : 5/5/1998
terry : 11/11/1997
terry : 11/11/1997
alopez : 6/11/1997
mark : 12/20/1996
jamie : 12/18/1996
mark : 12/11/1996
mark : 6/19/1996
terry : 4/15/1996
terry : 4/1/1996
terry : 3/22/1996
mark : 2/7/1996
mark : 2/7/1996

# 601042

DYSTONIA 9; DYT9


Alternative titles; symbols

CHOREOATHETOSIS/SPASTICITY, EPISODIC
CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA
CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY


SNOMEDCT: 715564000;   ORPHA: 53583;   DO: 0090044;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
1p34.2 Dystonia 9 601042 Autosomal dominant 3 SLC2A1 138140

TEXT

A number sign (#) is used with this entry because dystonia-9 (DYT9) is caused by heterozygous mutation in the SLC2A1 gene (138140), also referred to as GLUT1, on chromosome 1p34.

Allelic disorders with overlapping features include GLUT1 deficiency syndrome-1 (GLUT1DS1; 606777), GLUT1DS2 (612126), and idiopathic generalized epilepsy-12 (EIG12; 614847).


Description

Dystonia-9 is an autosomal dominant neurologic disorder characterized by childhood onset of paroxysmal choreoathetosis and progressive spastic paraplegia. Most show some degree of cognitive impairment. Other variable features may include seizures, migraine headaches, and ataxia (summary by Weber et al., 2011).


Clinical Features

Auburger et al. (1996) described a large German pedigree with autosomal dominant paroxysmal choreoathetosis and spasticity. A total of 18 affected and 11 unaffected family members were clinically evaluated. Age of onset ranged from 2 to 15 years, with most individuals presenting clear symptoms before attending school. Patients complained of episodes of involuntary movements, dystonic posture of toes, legs, and arms, imbalance, dysarthria, paresthesias periorally and on the lower limbs, and double vision, sometimes accompanied or followed by headache. Cerebellar ataxia was not seen in the episodes observed. The episodes lasted approximately 20 minutes, and occurred at frequencies ranging from twice a day to twice a year. Physical exercise, emotional stress, lack of sleep, and alcohol consumption were mentioned as precipitating factors. While physical examination was usually normal in the clinical interval, 5 patients exhibited constant spastic paraplegia as evidenced by spastic leg tone, increased tendon reflexes, and pyramidal signs in the lower limbs, without increased latencies on motor evoked potential analysis. Affected individuals were described as good natured and simple minded; 1 patient was 'analphabetic.'

Weber et al. (2011) reported Australian adult monozygotic twin brothers with DYT9 and mental retardation. They presented with paroxysmal choreoathetosis and progressive spastic paraparesis; ataxia was not observed. As toddlers, they both developed episodic stereotyped, abnormal movements mainly affecting the limbs. The movements progressed to vigorous choreatic movements without impairment of consciousness. Episodes lasted between 5 minutes and 2 hours, and occurred several times weekly. Precipitating factors included prolonged exercise or physical exhaustion, dehydration, caffeine, alcohol, and anticipation of food. Medication was not beneficial for these episodes. In addition, both had a persistent gait disturbance due to progressive spastic paraparesis since later childhood, with markedly increased tone, sustained clonus, pyramidal pattern weakness, brisk reflexes, and extensor plantar responses.


Inheritance

The transmission pattern of paroxysmal choreoathetosis in the family reported by Auburger et al. (1996) was consistent with autosomal dominant inheritance.


Clinical Management

Bain et al. (1992) demonstrated a rise in pH in the cerebellum with (31)P nuclear magnetic resonance spectroscopy in 6 affected members of 2 unrelated families with familial periodic cerebellar ataxia consistent with ataxia (see 108500). Consistent with this finding, acetazolamide stopped or alleviated symptoms. In contrast, Auburger et al. (1996) found no clear elevation of pH in their family. They stated, however, that episodes ceased in one patient after administration of acetazolamide and phenytoin and were ameliorated in a second patient by acetazolamide but continued in a third patient despite treatment with a range of agents.


Mapping

By linkage analysis in a large pedigree with paroxysmal choreoathetosis with episodic ataxia and spasticity, Auburger et al. (1996) concluded that the gene for this disorder probably lies in a 2-cM region between D1S443 and D1S197. They noted that a cluster of potassium channel genes is located on 1p.


Molecular Genetics

In affected members of the family with DYT9 originally reported by Auburger et al. (1996), Weber et al. (2011) identified a heterozygous mutation in the SLC2A1 gene (R232C; 138140.0018). Two Australian brothers with the disorder carried a different heterozygous mutation (R126C; 138140.0014).


Nomenclature

Muller et al. (1998) referred to this disorder as dystonia-9 and suggested that it is closely related to paroxysmal dystonic choreoathetosis (PDC; 118800), which they referred to as dystonia-8. The involuntary movements and dystonia in DYT9 are similar to those in PDC, which maps to chromosome 2. In both disorders, episodes can be induced by alcohol, fatigue, and emotional stress; however, in DYT9, physical exercise can precipitate the episodes, and 5 of the 18 patients studied by Auburger et al. (1996) had spastic paraplegia both during and between episodes of dyskinesia.


REFERENCES

  1. Auburger, G., Ratzlaff, T., Lunkes, A., Nelles, H. W., Leube, B., Binkofski, F., Kugel, H., Heindel, W., Seitz, R., Benecke, R., Witte, O. W., Voit, T. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 31: 90-94, 1996. [PubMed: 8808284] [Full Text: https://doi.org/10.1006/geno.1996.0013]

  2. Bain, P. G., O'Brien, M. D., Keevil, S. F., Porter, D. A. Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann. Neurol. 31: 147-154, 1992. [PubMed: 1575453] [Full Text: https://doi.org/10.1002/ana.410310205]

  3. Muller, U., Steinberger, D., Nemeth, A. H. Clinical and molecular genetics of primary dystonias. Neurogenetics 1: 165-177, 1998. [PubMed: 10737119] [Full Text: https://doi.org/10.1007/s100480050025]

  4. Weber, Y. G., Kamm, C., Suls, A., Kempfle, J., Kotschet, K., Schule, R., Wuttke, T. V., Maljevic, S., Liebrich, J., Gasser, T., Ludolph, A. C., Van Paesschen, W., Schols, L., De Jonghe, P., Auburger, G., Lerche, H. Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology 77: 959-964, 2011. [PubMed: 21832227] [Full Text: https://doi.org/10.1212/WNL.0b013e31822e0479]


Contributors:
Cassandra L. Kniffin - updated : 10/4/2012
Victor A. McKusick - updated : 5/5/1998
Orest Hurko - updated : 4/1/1996

Creation Date:
Victor A. McKusick : 2/6/1996

Edit History:
carol : 05/11/2017
joanna : 05/10/2013
carol : 10/9/2012
ckniffin : 10/4/2012
ckniffin : 10/4/2012
alopez : 4/6/2010
joanna : 3/18/2004
carol : 5/22/1998
carol : 5/16/1998
carol : 5/13/1998
terry : 5/5/1998
terry : 11/11/1997
terry : 11/11/1997
alopez : 6/11/1997
mark : 12/20/1996
jamie : 12/18/1996
mark : 12/11/1996
mark : 6/19/1996
terry : 4/15/1996
terry : 4/1/1996
terry : 3/22/1996
mark : 2/7/1996
mark : 2/7/1996